Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × Diphenhydramine × Clear all

Sponsor

Conditions

Vomiting 3 Neoplasm Metastasis 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, B-Cell 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Neoplasms 2 Nausea 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Leukemia, Hairy Cell 2 Leukemia 2 Kidney Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma in Situ 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Rectal Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Nausea and Vomiting 1 Philadelphia Chromosome 1 Pathologic Complete Response 1 Papillomavirus Infections 1 Oncology Patients Receiving Chemotherapy 1

Interventions

Paclitaxel 80 Carboplatin 76 Bevacizumab 53 Gemcitabine 29 pembrolizumab 27 liposomal doxorubicin 27 Topotecan 22 olaparib 19 Taxes 17 niraparib 15 Docetaxel 15 Immunoglobulin G 14 Disulfides 14 Cyclophosphamide 14 Cisplatin 11 durvalumab 10 Nivolumab 9 Doxorubicin 8 Albumin-Bound Paclitaxel 8 sargramostim 7 rucaparib 7 fludarabine phosphate 7 fludarabine 7 pazopanib 6 epacadostat 6 avelumab 6 Trabectedin 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 Interleukin-2 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡